How to buy HTG Molecular Diagnostics stock (HTGM)

HTG Molecular Diagnostics is a healthcare equipment & supplies business based in the US. HTG Molecular Diagnostics shares (HTGM) are listed on the NASDAQ and all prices are listed in US Dollars. HTG Molecular Diagnostics employs 53 staff and has a trailing 12-month revenue of around $6.2 million.

Our top picks for where to buy HTG Molecular Diagnostics stock

Buy HTG Molecular Diagnostics stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

HTG Molecular Diagnostics stock price (NASDAQ: HTGM)

Use our graph to track the performance of HTGM stocks over time.

HTG Molecular Diagnostics shares at a glance

• Key figures

Information last updated 2023-10-15.

52-week range	$0.00 - $0.00
50-day moving average more info button	$1.98
200-day moving average more info button	$4.21
Wall St. target price	$6.00
PE ratio more info button	N/A
Dividend yield more info button	$0 (0%)
Earnings per share (TTM) more info button	$-17.10

Is it a good time to buy HTG Molecular Diagnostics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

HTG Molecular Diagnostics financials

Revenue TTM	$6.2 million
Gross profit TTM	$-2,009,447
Return on assets TTM	-62.26%
Return on equity TTM	-343.21%
Profit margin	0%
Book value	$0.21
Market Capitalization more info button	$1.1 million

TTM: trailing 12 months

HTG Molecular Diagnostics share dividends

We're not expecting HTG Molecular Diagnostics to pay a dividend over the next 12 months.

Have HTG Molecular Diagnostics's shares ever split?

HTG Molecular Diagnostics's shares were split on a 1:12 basis on 20 December 2022 . So if you had owned 12 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your HTG Molecular Diagnostics shares – just the quantity. However, indirectly, the new 1100% higher share price could have impacted the market appetite for HTG Molecular Diagnostics shares which in turn could have impacted HTG Molecular Diagnostics's share price.

HTG Molecular Diagnostics share price volatility

Over the last 12 months, HTG Molecular Diagnostics's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while HTG Molecular Diagnostics's is 0.9926. This would suggest that HTG Molecular Diagnostics's shares are less volatile than average (for this exchange).

HTG Molecular Diagnostics overview

HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq Oncology Biomarker Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. The company was formerly known as HTG, Inc.

Frequently asked questions

null
What percentage of HTG Molecular Diagnostics is owned by insiders or institutions?
Currently 6.542% of HTG Molecular Diagnostics shares are held by insiders and 0.746% by institutions. How many people work for HTG Molecular Diagnostics?
Latest data suggests 53 work at HTG Molecular Diagnostics. When does the fiscal year end for HTG Molecular Diagnostics?
HTG Molecular Diagnostics's fiscal year ends in December. Where is HTG Molecular Diagnostics based?
HTG Molecular Diagnostics's address is: 3430 East Global Loop, Tucson, AZ, United States, 85706 What is HTG Molecular Diagnostics's ISIN number?
HTG Molecular Diagnostics's international securities identification number is: US40434H2031 What is HTG Molecular Diagnostics's CUSIP number?
HTG Molecular Diagnostics's Committee on Uniform Securities Identification Procedures number is: 40434H104